Ali Mobasheri Selected Research

Osteoarthritis

4/2022	Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial.
1/2022	Exploring the translational potential of clusterin as a biomarker of early osteoarthritis.
1/2022	WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes.
1/2022	A new immunometabolic perspective of intervertebral disc degeneration.
1/2022	Minimally Invasive Cell-Based Therapy for Symptomatic Bone Marrow Lesions of the Knee: A Prospective Clinical Study at 1 Year.
1/2022	Osteoarthritis endotype discovery via clustering of biochemical marker data.
1/2022	Blood and urine biomarkers in osteoarthritis - an update on cartilage associated type II collagen and aggrecan markers.
11/2021	Transcriptome-based screening of ion channels and transporters in a migratory chondroprogenitor cell line isolated from late-stage osteoarthritic cartilage.
10/2021	A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?
2/2021	An Update on the Role of Leptin in the Immuno-Metabolism of Cartilage.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Mobasheri Research Topics

Disease

74	Osteoarthritis 04/2022 - 12/2004
26	Inflammation (Inflammations) 01/2022 - 01/2009
18	Neoplasms (Cancer) 04/2019 - 06/2003
16	Pain (Aches) 04/2022 - 01/2012
8	Rheumatoid Arthritis 01/2022 - 11/2005
8	Joint Diseases (Joint Disease) 10/2021 - 01/2005
7	Knee Osteoarthritis 04/2022 - 07/2014
6	Arthritis (Polyarthritis) 01/2022 - 01/2011
6	Hypoxia (Hypoxemia) 11/2011 - 12/2006
5	Obesity 01/2022 - 03/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2018
4	Disease Progression 01/2020 - 01/2011
4	Rheumatic Diseases (Rheumatism) 04/2019 - 12/2014
4	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 01/2013
3	COVID-19 07/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 09/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2022 - 10/2021
2	Musculoskeletal Diseases (Musculoskeletal Disease) 10/2021 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2021
2	Chronic Pain 01/2021 - 12/2014
2	Necrosis 06/2020 - 01/2019
2	Metabolic Diseases (Metabolic Disease) 02/2020 - 01/2015
2	Hypertension (High Blood Pressure) 01/2019 - 04/2010
2	Adenocarcinoma 09/2017 - 06/2003
2	Wounds and Injuries (Trauma) 03/2015 - 01/2010
2	Diabetes Mellitus 12/2014 - 01/2009
2	Osteoporosis 07/2013 - 04/2011
1	Knee Injuries (Knee Injury) 01/2022
1	Starvation 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Cholestasis 10/2021
1	Cartilage Diseases (Cartilage Disease) 02/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2021
1	Weight Loss (Weight Reduction) 01/2021

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2010
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
15	CytokinesIBA 01/2022 - 12/2004
12	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
11	CurcuminIBA 01/2019 - 12/2004
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2008
7	ResveratrolIBA 07/2013 - 12/2008
5	AdipokinesIBA 01/2022 - 01/2015
5	Protein Isoforms (Isoforms)IBA 11/2017 - 06/2003
5	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 12/2006
5	Aquaporins (Water Channels)IBA 03/2014 - 05/2005
5	Interleukin-1beta (Interleukin 1 beta)IBA 01/2013 - 12/2004
4	Biological ProductsIBA 01/2022 - 12/2013
4	CollagenIBA 10/2021 - 11/2012
4	PhytochemicalsIBA 04/2019 - 01/2012
4	Transcription Factors (Transcription Factor)IBA 11/2012 - 01/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 12/2004
4	NF-kappa B (NF-kB)IBA 08/2011 - 12/2004
3	EnzymesIBA 01/2022 - 01/2012
3	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 04/2010
3	Glucosamine (Dona)IBA 01/2018 - 01/2012
3	Adenosine Triphosphatases (ATPase)IBA 11/2017 - 06/2003
3	InterleukinsIBA 01/2012 - 01/2010
3	Matrix Metalloproteinases (MMPs)IBA 11/2011 - 01/2009
3	cobaltous chloride (cobalt(II)chloride)IBA 11/2011 - 12/2006
3	Oxygen (Dioxygen)IBA 04/2009 - 12/2006
2	Hyaluronic Acid (Hyaluronan)IBA 04/2022 - 01/2021
2	SteroidsIBA 04/2022 - 01/2015
2	ClusterinIBA 01/2022 - 01/2021
2	LeptinIBA 02/2021 - 11/2015
2	LipidsIBA 01/2021 - 01/2018
2	Ion Channels (Ion Channel)IBA 01/2021 - 11/2017
2	Sirtuin 1IBA 10/2020 - 01/2017
2	Nifedipine (Adalat)FDA LinkGeneric 01/2019 - 07/2015
2	Calcium Channels (Calcium Channel)IBA 01/2019 - 07/2015
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2011
2	Plant ExtractsIBA 01/2018 - 12/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2017 - 04/2017
2	SirtuinsIBA 01/2016 - 01/2016
2	lubricinIBA 03/2015 - 06/2014
2	LipopolysaccharidesIBA 01/2015 - 01/2013
2	NeuropeptidesIBA 08/2014 - 01/2009
2	Proteoglycans (Proteoglycan)IBA 06/2014 - 01/2011
2	Caspase 3 (Caspase-3)IBA 07/2012 - 01/2009
2	Aquaporin 1IBA 04/2010 - 05/2005
1	Peptides (Polypeptides)IBA 01/2022
1	Aggrecans (Aggrecan)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Collagen Type II (Type II Collagen)IBA 01/2022
1	trichrome stainIBA 10/2021
1	Bile Acids and Salts (Bile Acids)IBA 10/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Cardiovascular AgentsIBA 01/2021
1	NexusIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2005
5	Drug Therapy (Chemotherapy) 07/2021 - 01/2013
2	Intra-Articular Injections 04/2022 - 01/2021
2	Injections 01/2021 - 01/2021
1	Aftercare (After-Treatment) 04/2022
1	Activities of Daily Living (ADL) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020